Kris Kuchenbecker, PhD
Chief Science & Technology Officer
Silver Creek Pharmaceuticals
Kris Kuchenbecker designed Silver Creek's lead molecule, scp776. He has been with the company for 10 years. In his time at Silver Creek, Kris has developed a computational model of damage-specific pro-survival signaling, overseen the scale-up of the production process and manufacturing, and led the regulatory and operational efforts for our development programs.
Kris attended UC Berkeley, where he played volleyball and studied biochemistry and molecular biology with an emphasis in physical chemistry. After his undergraduate studies, he worked in David Jablons' lab at the UCSF Cancer Center. Kris enrolled in the Biophysics PhD program at UCSF in 2005, joining Robert Fletterick's lab in the Macromolecular Structure Group.
In graduate school, Kris focused on the molecular recognition properties of transcriptional regulators. His thesis emphasized structural biology, computational modeling, and quantitative measurement of these interactions.
Speaking In
-
04-Jun-2024Silver Creek PharmaceuticalsCompany Presentation Theater 1